---
schema_version: "secwatch.filing_event.v1"
accession: "0001824293-24-000159"
form_type: "8-K"
ticker: "GRI"
cik: "0001824293"
company_name: "GRI Bio, Inc."
filed_at: "2024-12-20T23:59:59+00:00"
generated_at: "2026-05-29T00:28:27.988090+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# GRI Bio increases at-the-market offering capacity to $322,468 after $3.6M already sold

## Summary
- On December 20, 2024, GRI Bio filed a prospectus supplement to increase shares issuable under its ATM agreement with H.C. Wainwright to up to $322,468.
- The company had previously sold approximately $3,604,683 of shares under the same Sales Agreement dated May 20, 2024.
- An opinion from Mintz, Levin law firm on the legality of the share issuance was attached as Exhibit 5.1.

## SEC filing metadata
- accession: 0001824293-24-000159
- form_type: 8-K
- ticker: GRI
- cik: 0001824293
- company_name: GRI Bio, Inc.
- filed_at: 2024-12-20T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1824293/000182429324000159/0001824293-24-000159-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1824293/000182429324000159/val-20241220.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001824293-24-000159
- JSON: https://secwatch.observer/filing/0001824293-24-000159.json
- Plain text: https://secwatch.observer/filing/0001824293-24-000159.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.